BamSEC and AlphaSense Join Forces
Learn More

Zenas BioPharma Inc. – Material Contracts

NASDAQ: ZBIO    
Share price (11/6/26): $28.26    
Market cap (11/6/26): $1.917 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 8 pages ​ Consulting Agreement
12/34/56
EX-10.2
from 10-Q 19 pages Confidential ​ August 12, 2026 ​ Personal and Confidential ​ Jennifer Fox 201 E. 87th Street, Php Ny, Ny 10128 ​ Re:transition Agreement ​ Dear Jen, ​
12/34/56
EX-10.1
from 10-Q 14 pages Zenas Biopharma, Inc. 2024 Employee Stock Purchase Plan
12/34/56
EX-10.4
from 10-Q 5 pages First Amendment to Revenue Participation Right Purchase and Sale Agreement ​
12/34/56
EX-10.2
from 10-Q 5 pages ​ Amendment No. 3 to License Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Letter Agreement for Collaboration on [***] Clinical Trial for Zb021/Icp-054
12/34/56
EX-10.31
from 10-K 71 pages License Agreement
12/34/56
EX-10.25
from 10-K 19 pages ​ February 17, 2025 Lisa Von Moltke Dear Lisa: On Behalf of Zenas BioPharma (USA) LLC (The “Company”), I Am Very Pleased to Offer You Employment as Chief Medical Officer and Head of Research and Development. the Terms of Your Employment With the Company Are as Set Forth Below (This Letter Agreement, the “Agreement”): 1. Position. A.YOU Will Be Employed, on a Full-Time Basis, as Chief Medical Officer and Head of Research and Development of the Company
12/34/56
EX-10.19
from 10-K 2 pages Zenas Biopharma, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.14
from 10-K 6 pages Zenas BioPharma Amended and Restated Short-Term Incentive Plan ​ January 1, 2026 ​
12/34/56
EX-10.1
from 8-K 6 pages Zenas BioPharma Amended and Restated Short-Term Incentive Plan January 1, 2026
12/34/56
EX-10.5
from 8-K 24 pages Zenas Biopharma, Inc. 2026 Inducement Plan Global Restricted Stock Unit Agreement
12/34/56
EX-10.4
from 8-K 16 pages Zenas Biopharma, Inc. 2026 Inducement Plan Global Non-Statutory Stock Option Agreement
12/34/56
EX-10.3
from 8-K 5 pages Zenas Biopharma, Inc. 2026 Inducement Plan Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 8-K 4 pages Zenas Biopharma, Inc. 2026 Inducement Plan Non-Statutory Stock Option Agreement
12/34/56
EX-10.1
from 8-K 14 pages Zenas Biopharma, Inc. 2026 Inducement Plan
12/34/56
EX-10.1
from 10-Q 51 pages Revenue Participation Right Purchase and Sale Agreement by and Between Zenas Biopharma, Inc. and Royalty Pharma Investments 2019 Icav Dated as of September 2, 2025 ​
12/34/56
EX-10.4
from 8-K 21 pages Form of Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 42 pages Form of Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56